Smarter Decisions, Superior Outcomes

Monitoring PDMP Effectiveness Now and in the Future

Posted by Denika Hockenhull on May 16, 2016 at 10:30 AM

HID had the honor of leading honored a Vision Session during the 5th Annual National Rx Drug Abuse & Heroin Summit that was held March 28-31 in Atlanta, Georgia.

Titled “Monitoring PDMP Effectiveness Now and in the Future,”  HID’s presentation focused on how data accessibility and enhancement are effective tools for protecting public health and safety while supporting sound clinical prescribing, dispensing, and use of controlled substances. Attendees discovered:

  • How collaborative partnerships support state PDMP goals and outcomes
  • Why public and private health plans will require PDMP data
  • How the ONC’s Interoperability Roadmap will change the way PDMP data is accessed

Program Manager Rebecca Poston, MPH, RPH, was on hand to speak on the tremendous success accomplished by E-FORCSE, the State of Florida’s PDMP. E-FORCSE has experienced real, tangible, positive outcomes since 2010 when the program began and HID’s RxSentry solution was implemented.

If you've missed this year's Summit, don't worry. Our team has provided the presentation slides and a brief recap after the jump!

Read More

Topics: Interoperability, state health, opioids, PDMP, population health, healthIT, data accessibility

4 Essential Keys to a Solid ePA Knowledge-base

Posted by Kathleen Sabo on February 2, 2016 at 8:30 AM

ePA will continue to gain momentum.

Electronic Prior Authorization (ePA) is not going anywhere—and, we're not talking about the folks who test drinking water and lobby for reduction of air pollutants. There has been a lot of talk about ePA over the past year. In fact, Google records nearly 3.9 million results for the term and nearly every week there is a legislative update, industry news story, or forum on the topic. Don't expect that to change this year.

With benefit managers struggling under the weight of requirements from Federal rules like HIPAA, HITECH, and Meaningful Use, as well as State regulations, ePA has become an essential strategy for the evolution of pharmacy benefit programming and maintaining regulatory standards. However, the value of ePA reaches much further than compliance. ePA substantially increases efficiency in the continuum of care for everyone, including providers, dispensers, patients, health plans, and payors. Faxing forms is cumbersome and depends on old, outdated technology. With ePA, a determination can be received in just minutes, often times when the patient is still in the doctor's office. And, this value is what providers have been waiting for.

Read More

Topics: Interoperability, NCPDP Standards, ePA, Meaningful Use, Coverage Determination Process, Prior Authorization, Interoperability Roadmap

Independent & Objective

Clinical expertise without the noise

Getting the facts matters. Following our corporate mission, we're committed to using this blog to enhance your knowledge of evolutionary events and discussions in the pharmacy services and technology arena. 

Here's what we're focused on right now:

  • Lowering ingredient cost
  • Enhancing the coverage determination process
  • Creating robust prior authorization criteria
  • Producing actionable drug trend analyses
  • Enhancing prescription drug monitoring 
  • Implementing interoperability efforts

Subscribe to Email Updates

Recent Posts